TumerikAI

Patient recruitment for clinical trials is a costly bottleneck, ranging anywhere from $600k to $8M to recruit and retain one patient. As of 2024, the FDA mandates diversity in clinical trials, with non-compliance resulting in trial rejection. This causes costly market delays and hinders scientific progress, emphasizing the urgent need for inclusive trial practices.

TumerikAI bridges the gap between doctors and hospitals managing complex datasets for scientific advancement and diverse patients looking for trials. Our Global Site Network has enhanced functionality to expand the pool of eligible patients for doctors, hospitals, and biopharma.